No Data
SIGA Technologies Shares Are Trading Lower After Interim Results From the STOMP Study Showed That Tecovirimat Did Not Improve the Time to Lesion Resolution Compared to Placebo in Adults With Mild to Moderate Clade II Mpox.
Express News | SIGA Technologies Inc - Efficacy in Severe Mpox Patients Not Assessed in Study
Express News | SIGA Technologies Inc - Study Stopped Enrolling Patients in All Study Arms
Express News | Interim Results From Stomp Study of Siga’s Tecovirimat in Treatment of Mpox Announced
Express News | Nih: Data Safety and Monitoring Board Recommended Stopping Further Enrollment of Participants Who Were Being Randomized to Tecovirimat or Placebo
'NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution Or Pain'
Unlock the Full List
Lnova : What do you think about the stock that I saw browny shared this week, I was thinking maybe mpox could also be a catalyst for
. Then again I’m not sure how far their product is in its development. One sec
Jaguar8 OP Lnova : I don’t know what he posted
Lnova Jaguar8 OP : One sec, it’s $Polyrizon (PLRZ.US)$ , I noticed in their company profile, “The company is a biotechnology company in clinical development that specializes in developing innovative hydrogels provided in the form of nasal sprays and creating a thin hydrogel-based barrier in the nasal cavity that can provide a barrier against viruses and allergens coming into contact with nasal epithelial tissue. The company's proprietary C&C hydrogel technology consists of a mixture of natural building blocks, provided as a nasal spray, and has the potential to serve as a ‘biological mask’ with a thin shielding barrier in the nasal cavity.”
Lnova : plzr product may still be in development stage, but, I was intrigued by their product description. So it’s one company I will keep an eye on, especially with viruses/pandemics, etc.
Lnova Jaguar8 OP : sorry btw I don’t mean to spam you lol. I just found the product they’re developing to be interesting
View more comments...